» Articles » PMID: 38932119

Cytokinins Reduce Viral Replication and Alter Plaque Morphology of Frog Virus 3 In Vitro

Overview
Journal Viruses
Publisher MDPI
Specialty Microbiology
Date 2024 Jun 27
PMID 38932119
Authors
Affiliations
Soon will be listed here.
Abstract

Cytokinins (CKs) are a group of N-substituted signaling molecules whose biosynthesis and metabolism have been documented in all kingdoms of life, including vertebrates. While their biological relevance in vertebrate systems continues to be elucidated, they have broadly been documented with therapeutic effects in exogenous applications. In this study, we evaluated the virostatic potential of four types of CKs including, -isopentenyladenine (iP), -isopentenyladenosine (iPR), -isopentenyladenosine-5'monophosphate (iPMP), and 2-methylthiol--isopentenyladenosine (2MeSiPR) against the ranavirus type species, frog virus 3 (FV3). Following concurrent treatment and infection, iP and iPR reduced viral replication by 33.8% and 59.6%, respectively, in plaque formation assays. A decrease in viral replication was also observed when CK exposure was limited to 12 h prior to infection, where iP and iPR reduced viral replication by 31% and 23.75%, respectively. Treatment with iP and iPR was also marked by 48% and 60% decreases in viral load over 72 h, respectively, as measured in single step growth curves. Plaque morphology was altered in vitro, as iP and iPR treatment increased plaque area by 83% and 112% with lytic zone formation also becoming more prevalent in corresponding treatments. Treatment with iPMP and 2MeSiPR resulted in no effect on viral kinetics in vitro. The results of this study are the first to provide evidence of CK antiviral activity against a DNA virus and highlight the importance of their structure for therapeutic investigations.

References
1.
Koonin E, Yutin N . Evolution of the Large Nucleocytoplasmic DNA Viruses of Eukaryotes and Convergent Origins of Viral Gigantism. Adv Virus Res. 2019; 103:167-202. DOI: 10.1016/bs.aivir.2018.09.002. View

2.
Dassano A, Mancuso M, Giardullo P, De Cecco L, Ciuffreda P, Santaniello E . N(6)-isopentenyladenosine and analogs activate the NRF2-mediated antioxidant response. Redox Biol. 2014; 2:580-9. PMC: 3969604. DOI: 10.1016/j.redox.2014.03.001. View

3.
Ciaglia E, Pisanti S, Picardi P, Laezza C, Sosa S, Tubaro A . N6-isopentenyladenosine affects cytotoxic activity and cytokines production by IL-2 activated NK cells and exerts topical anti-inflammatory activity in mice. Pharmacol Res. 2014; 89:1-10. DOI: 10.1016/j.phrs.2014.07.003. View

4.
Bhutta M, Gallo E, Borenstein R . Multifaceted Role of AMPK in Viral Infections. Cells. 2021; 10(5). PMC: 8148118. DOI: 10.3390/cells10051118. View

5.
Li M, Qi Y, Wei J, Lu L, Zhao X, Zhou L . N6-Isopentenyladenosine promoted HeLa cell apoptosis through inhibitions of AKT and transforming growth factor β-activated kinase 1 activation. Tumour Biol. 2017; 39(3):1010428317695966. DOI: 10.1177/1010428317695966. View